-+ 0.00%
-+ 0.00%
-+ 0.00%

Apimeds Pharmaceuticals US Files Initial Beneficial Ownership Statement for Co-CEO Sungjoon Chae

PUBT·11/05/2026 19:59:32
Listen to the news
Apimeds Pharmaceuticals US Files Initial Beneficial Ownership Statement for Co-CEO Sungjoon Chae
  • Apimeds Pharmaceuticals US Co-Chief Executive Officer Sungjoon Chae filed an initial statement of beneficial ownership.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Apimeds Pharmaceuticals US Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0002163547-26-000001), on November 05, 2026, and is solely responsible for the information contained therein.